Bioventus Inc (BVS) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 27 2026 to Jun 28 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bioventus Inc   (NASDAQ: BVS)

Bioventus Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bioventus Inc in the second quarter 2026?
Bioventus Inc achieved a return on average equity (ROE) of 25.96 % in its second quarter 2026 a new company high.

ROE has advanced compared to 15.86% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 9 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 741 to 893.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Equity Change 37.81 % 26.3 % 23.08 % 10.93 % -
Y / Y Net Income Change 290.48 % - - - -
Net Income (TTM) in Millions 61 35 27 10 0
Return On Equity (TTM) 25.96 % 15.86 % 13.26 % 5.03 % 0.2 %
BVS's Total Ranking # 893 # 741 # 627 # 954 #
Equity (TTM) in Millions 277 234 228 207 201
Seq. Equity Change 18.42 % 2.55 % 10.23 % 2.96 % 8.53 %
Seq. Net Income Change 817.51 % -77.21 % 332.3 % -56.79 % -

Back to BVS Management Effectiveness >> BVS's 5 Years Annual ROE >> Compare BVS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 10
Sector # 63
Overall # 893

Return On Equity Statistics
High Average Low
25.96 %
-23.68 %
-110.62 %
(Jun 27 2026)   (Jul 01 2023)





BVS Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 228 186 221 340 534
Y / Y Equity Change 23.08 % -16.06 % -35.03 % -36.24 % -
Net Income in Millions 27 -44 -196 -213 10
Y / Y Net Income Change - - - - -
Return On Equity 11.94 % -23.62 % -88.47 % -62.7 % 1.8 %

Back to BVS Management Effectiveness >> BVS's 5 Years Annual ROE >> Compare BVS ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 11.94 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BVS's' Return on Equity at Yahoo Finance
BVS's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BVS's Competitors
Subscribers only: Roe for Bioventus Inc 's Suppliers
Subscribers only: Return On Equity for BVS's Customers




Companies with similar Return On Equity at Jun 27 2026, within Healthcare Sector ROE
Elite Pharmaceuticals Inc   71.10 %
Zoetis Inc   68.87 %
Rallybio Corporation  68.56 %
Earth Science Tech Inc   66.17 %
Aurinia Pharmaceuticals Inc   59.00 %
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %

Date modified: 2026-09-09T22:40:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.